FIXX RSI Chart
Last 7 days
1715.2%
Last 30 days
1987.5%
Last 90 days
2829.8%
Trailing 12 Months
1657.9%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 3.9M | 3.4M | 4.0M | 3.2M |
2022 | 26.3M | 18.6M | 10.9M | 3.2M |
2021 | 31.4M | 33.0M | 34.1M | 34.0M |
2020 | 1.9M | 2.2M | 2.4M | 2.7M |
2019 | 4.5M | 4.8M | 4.9M | 1.7M |
2018 | 0 | 0 | 4.3M | 4.3M |
2017 | 0 | 0 | 0 | 0 |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 25, 2024 | alloway paul | acquired | - | - | 23,530 | see remarks |
Mar 25, 2024 | michaud charles jr | acquired | - | - | 6,448 | see remarks |
Jan 09, 2024 | tzianabos arthur | sold | -7,445 | 0.5711 | -13,037 | - |
Jan 03, 2024 | alloway paul | sold | -4,120 | 0.566 | -7,280 | see remarks |
Jan 03, 2024 | michaud charles jr | sold | -975 | 0.571 | -1,708 | see remarks |
Jan 01, 2024 | michaud charles jr | acquired | - | - | 4,240 | see remarks |
Jan 01, 2024 | tzianabos arthur | acquired | - | - | 33,420 | - |
Jan 01, 2024 | alloway paul | acquired | - | - | 18,610 | see remarks |
Sep 06, 2023 | seymour albert | acquired | - | - | 4,620 | see remarks |
Sep 06, 2023 | seymour albert | sold | -1,665 | 1.1502 | -1,448 | see remarks |
Which funds bought or sold FIXX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 11, 2024 | VANGUARD GROUP INC | reduced | -5.22 | -1,215,070 | 1,179,270 | -% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 95.14 | 420 | 30,222 | -% |
Feb 27, 2024 | Beaird Harris Wealth Management, LLC | sold off | -100 | -191 | - | -% |
Feb 26, 2024 | Virtu Financial LLC | new | - | 21,000 | 21,000 | -% |
Feb 15, 2024 | BARCLAYS PLC | unchanged | - | -30,000 | 33,000 | -% |
Feb 15, 2024 | JANE STREET GROUP, LLC | new | - | 14,379 | 14,379 | -% |
Feb 14, 2024 | TWO SIGMA SECURITIES, LLC | sold off | -100 | -11,775 | - | -% |
Feb 14, 2024 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | reduced | -14.13 | -74,764 | 60,241 | -% |
Feb 14, 2024 | Western Standard LLC | sold off | -100 | -292,570 | - | -% |
Feb 14, 2024 | Newtyn Management, LLC | new | - | 850,750 | 850,750 | 0.17% |
Unveiling Homology Medicines Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Homology Medicines Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 42.3B | 6.8B | -8.96 | 6.17 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 19.4B | 1.8B | -44.17 | 10.64 | ||||
BMRN | 16.7B | 2.4B | 99.73 | 6.91 | ||||
INCY | 12.8B | 3.7B | 21.46 | 3.47 | ||||
MID-CAP | ||||||||
APLS | 7.1B | 396.6M | -13.34 | 17.78 | ||||
BBIO | 5.4B | - | -8.31 | 60.35 | ||||
AXSM | 3.8B | 270.6M | -15.68 | 13.86 | ||||
ARWR | 3.6B | 240.7M | -11.98 | 14.77 | ||||
ACAD | 3.0B | 726.4M | -48.93 | 4.13 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 398.2M | 26.85 | 4.82 | ||||
NVAX | 678.8M | 983.7M | -1.25 | 0.69 | ||||
CRBP | 373.2M | 881.7K | -8.37 | 466.16 | ||||
INO | 304.5M | 4.9M | -2.25 | 62.57 | ||||
IBIO | 11.8M | 2.1M | -0.43 | 2.14 |
Homology Medicines Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | -100.0% | - | 1,423,000 | 354,000 | 1,469,000 | 802,000 | 802,000 | 802,000 | 802,000 | 802,000 | 1,677,000 | 2,187,000 | 29,305,000 | 980,000 | 567,000 | 567,000 | 588,000 | 1,124,500 | 1,661,000 | 1,703,000 | 1,271,000 | 223,000 |
Operating Expenses | -61.0% | 12,101,000 | 31,001,000 | 31,170,000 | 28,313,000 | 35,296,000 | 33,664,000 | 29,109,000 | 38,420,000 | 34,427,000 | 32,338,000 | 32,739,000 | 30,416,000 | 30,781,500 | 28,840,000 | 36,264,000 | 37,080,000 | 26,122,000 | 31,729,000 | 28,365,000 | 25,393,000 | 21,368,500 |
S&GA Expenses | 15.5% | 7,901,000 | 6,842,000 | 8,188,000 | 8,325,000 | 8,147,000 | 7,810,000 | 8,034,000 | 14,147,000 | 10,781,000 | 8,351,000 | 9,042,000 | 8,661,000 | 7,587,000 | 8,423,000 | 8,793,000 | 7,770,000 | 5,779,000 | 6,038,000 | 5,538,000 | 4,857,000 | 5,094,500 |
R&D Expenses | -91.4% | 1,513,000 | 17,519,000 | 22,982,000 | 19,988,000 | 27,149,000 | 25,854,000 | 21,075,000 | 24,273,000 | 23,646,000 | 23,987,000 | 23,697,000 | 21,755,000 | 23,194,500 | 20,417,000 | 27,471,000 | 29,310,000 | 20,343,000 | 25,691,000 | 22,827,000 | 20,536,000 | 16,274,000 |
EBITDA Margin | 7.8% | -26.66 | -28.93 | -34.71 | -30.29 | 0.76 | 0.34 | 0.35 | 0.21 | -2.57 | - | - | - | - | - | - | - | - | - | - | - | - |
Income Taxes | - | - | - | - | - | -212,000 | -46,000 | 100,000 | 1,000,000 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings Before Taxes | 92.7% | -2,155,000 | -29,578,000 | -29,305,000 | -26,042,000 | -33,039,000 | -31,593,000 | -27,833,000 | 93,663,000 | -33,583,000 | -30,608,000 | -30,500,000 | -1,073,000 | - | - | - | - | - | - | - | - | - |
EBT Margin | 7.9% | -26.83 | -29.14 | -35.01 | -30.58 | 0.37 | 0.06 | 0.09 | -0.04 | -2.82 | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income | 51.1% | -16,119,000 | -32,954,000 | -35,044,000 | -28,844,000 | -34,295,000 | -33,726,000 | -29,089,000 | 92,105,000 | -33,583,000 | -30,608,000 | -30,500,000 | -1,073,000 | -29,791,000 | -28,232,000 | -35,340,000 | -35,331,000 | -24,167,000 | -29,627,000 | -26,270,000 | -23,852,000 | -18,786,000 |
Net Income Margin | -7.4% | -34.80 | -32.40 | -38.49 | -32.50 | -1.56 | -0.39 | -0.06 | -0.10 | -2.82 | -2.69 | -2.71 | -3.01 | - | - | - | - | - | - | - | - | - |
Free Cashflow | 13.5% | -21,575,000 | -24,941,000 | -23,660,000 | -26,282,000 | -27,208,000 | -24,938,000 | -30,967,000 | -31,833,000 | -30,768,000 | -25,864,000 | -24,875,000 | -30,640,000 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | -39.6% | 85.00 | 140 | 169 | 198 | 228 | 263 | 285 | 311 | 212 | 231 | 259 | 235 | 264 | 228 | 258 | 289 | 311 | 317 | 341 | 233 | 259 |
Current Assets | -21.3% | 84.00 | 107 | 131 | 154 | 181 | 213 | 238 | 262 | 192 | 192 | 218 | 192 | 220 | 181 | 210 | 238 | 267 | 274 | 299 | 191 | 222 |
Cash Equivalents | 34.9% | 39.00 | 29.00 | 77.00 | 39.00 | 34.00 | 43.00 | 176 | 248 | 108 | 96.00 | 116 | 104 | 217 | 178 | 168 | 143 | 54.00 | 78.00 | 116 | 41.00 | 38.00 |
Net PPE | - | - | - | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 | 33.00 | 34.00 | 36.00 | 37.00 | 40.00 | 41.00 | 43.00 | 43.00 | 41.00 | 41.00 | 41.00 | 36.00 |
Liabilities | -77.7% | 12.00 | 52.00 | 50.00 | 46.00 | 50.00 | 54.00 | 44.00 | 45.00 | 42.00 | 32.00 | 34.00 | 34.00 | 68.00 | 58.00 | 64.00 | 62.00 | 52.00 | 59.00 | 56.00 | 59.00 | 63.00 |
Current Liabilities | -54.2% | 12.00 | 25.00 | 23.00 | 19.00 | 23.00 | 25.00 | 21.00 | 21.00 | 17.00 | 19.00 | 20.00 | 18.00 | 23.00 | 17.00 | 20.00 | 17.00 | 12.00 | 19.00 | 15.00 | 18.00 | 23.00 |
Shareholder's Equity | -17.3% | 73.00 | 88.00 | 119 | 152 | 178 | 209 | 240 | 266 | 170 | 199 | 225 | 201 | 196 | 170 | 195 | 227 | 259 | 258 | 285 | 174 | 196 |
Retained Earnings | -3.1% | -542 | -525 | -493 | -458 | -429 | -394 | -361 | -332 | -424 | -390 | -359 | -329 | -328 | -298 | -270 | -235 | -199 | -175 | -145 | -119 | -95.76 |
Additional Paid-In Capital | -100.0% | - | 614 | 612 | 610 | 608 | 604 | 601 | 598 | 594 | 589 | 585 | 530 | 524 | 469 | 465 | 462 | 458 | 433 | 430 | 294 | 292 |
Shares Outstanding | 0.2% | 58.00 | 58.00 | 58.00 | 58.00 | 57.00 | 57.00 | 57.00 | 57.00 | 57.00 | 55.00 | 53.00 | 50.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | - | - | - | 92.00 | - | - | - | 339 | - | - | - | 512 | - | - | - | 514 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | 13.5% | -21,575 | -24,941 | -23,660 | -26,054 | -27,199 | -24,932 | -30,846 | -30,684 | -30,430 | -25,387 | -24,111 | -29,823 | -11,612 | -28,887 | -27,987 | -25,846 | -26,333 | -25,484 | -21,670 | -17,871 | -8,079 |
Share Based Compensation | -50.4% | 847 | 1,706 | 2,402 | 2,369 | 3,089 | 2,771 | 3,143 | 4,051 | 4,663 | 4,226 | 4,473 | 3,883 | 3,566 | 3,346 | 3,453 | 2,883 | 2,436 | 1,986 | 1,970 | 1,243 | 955 |
Cashflow From Investing | 239.3% | 31,716 | -22,763 | 61,001 | 31,372 | 17,991 | -108,218 | -41,369 | 168,312 | 43,661 | 4,524 | -13,738 | -85,235 | -955 | 38,844 | 52,010 | 114,997 | -20,027 | -13,137 | -38,302 | 19,667 | 10,202 |
Cashflow From Financing | -22.2% | 14.00 | 18.00 | 2.00 | 150 | 32.00 | 124 | - | 440 | 1.00 | 379 | 49,746 | 2,043 | 51,995 | 410 | 241 | 447 | 22,575 | 614 | 134,699 | 325 | 41.00 |
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands | 12 Months Ended | |
---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
Statement of Comprehensive Income [Abstract] | ||
Collaboration revenue | $ 1,156 | $ 3,208 |
Operating expenses: | ||
Research and development | 62,002 | 98,351 |
General and administrative | 31,256 | 38,138 |
Restructuring and Other Charges | 9,327 | 0 |
Total operating expenses | 102,585 | 136,489 |
Loss from operations | (101,429) | (133,281) |
Other income: | ||
Gain on sale of business | 0 | 131,249 |
Gain on lease termination | 8,767 | 0 |
Interest income | 5,582 | 3,230 |
Total other income | 14,349 | 134,479 |
Income (loss) before income taxes | (87,080) | 1,198 |
Provision for income taxes | 0 | (715) |
Loss from equity method investment | (25,881) | (5,488) |
Net loss | $ (112,961) | $ (5,005) |
Net loss per share-basic | $ (1.95) | $ (0.09) |
Net loss per share-diluted | $ (1.95) | $ (0.09) |
Weighted average common shares outstanding-basic | 57,834,819 | 57,399,762 |
Weighted average common shares outstanding-diluted | 57,834,819 | 57,399,762 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 39,266 | $ 33,986 |
Short-term investments | 43,387 | 141,040 |
Assets Held For Sale | 260 | 0 |
Prepaid expenses and other current assets | 1,001 | 5,989 |
Total current assets | 83,914 | 181,015 |
Equity method investment | 0 | 25,814 |
Property and equipment, net | 0 | 1,078 |
Right-of-use assets | 650 | 20,563 |
Total assets | 84,564 | 228,470 |
Current liabilities: | ||
Accounts payable | 3,234 | 1,144 |
Accrued expenses and other liabilities | 7,021 | 18,715 |
Operating Lease Liabilities | 1,318 | 1,561 |
Deferred revenue | 0 | 1,156 |
Total current liabilities | 11,573 | 22,576 |
Non-current liabilities: | ||
Operating lease liabilities, net of current portion | 0 | 27,916 |
Total liabilities | 11,573 | 50,492 |
Commitments and contingencies (Note 10) | ||
Stockholders’ equity: | ||
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares issued and outstanding at December 31, 2023 and 2022 | 0 | 0 |
Common stock, $0.0001 par value; 200,000,000 shares authorized; 58,017,412 and 57,483,910 shares issued and outstanding as of December 31, 2023 and 2022, respectively | 6 | 6 |
Additional paid-in capital | 615,088 | 607,513 |
Accumulated other comprehensive gain | (5) | (404) |
Accumulated deficit | (542,098) | (429,137) |
Total stockholders’ equity | 72,991 | 177,978 |
Total liabilities and stockholders' equity | $ 84,564 | $ 228,470 |